Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1981 AL 1995

Opportunities and challenges for the development of M(1) muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

Nguyen HTM, van der Westhuizen ET, Langmead CJ, Tobin AB, Sexton PM, Christopoulos A, Valant C.

Br J Pharmacol. 2024 Jul;181(14):2114-2142. doi: 10.1111/bph.15982. Epub 2022 Dec 4.

Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics

Avgerinos KI, Mullins RJ, Vreones M, Mustapic M, Chen Q, Melvin D, Kapogiannis D, Egan JM.

Cells. 2022 Oct 25;11(21):3372. doi: 10.3390/cells11213372.

Exploring New Vista for Alzheimer's Disease Drug Targets

Kumar D.

Curr Top Med Chem. 2022;22(22):1847-1848. doi: 10.2174/156802662222221007161622.

Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications

Joshi M, Joshi S, Khambete M, Degani M.

Chem Biol Drug Des. 2023 Feb;101(2):453-468. doi: 10.1111/cbdd.14175. Epub 2022 Dec 7.

The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review

Ferreira D, Mohanty R, Murray ME, Nordberg A, Kantarci K, Westman E.

Acta Neuropathol Commun. 2022 Nov 14;10(1):166. doi: 10.1186/s40478-022-01471-z.

Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

Basli A, Bounaas J.

Nutr Health. 2023 Sep;29(3):403-413. doi: 10.1177/02601060221137104. Epub 2022 Nov 14.

Ginsenoside Rg1 in neurological diseases: From bench to bedside

Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ.

Acta Pharmacol Sin. 2023 May;44(5):913-930. doi: 10.1038/s41401-022-01022-1. Epub 2022 Nov 15.

Alzheimer's Disease: Treatment Strategies and Their Limitations

Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E.

Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.

Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights

Oliyaei N, Moosavi-Nasab M, Tanideh N, Iraji A.

Brain Res Bull. 2023 Feb;193:11-21. doi: 10.1016/j.brainresbull.2022.11.018. Epub 2022 Nov 23.

Exosome-based approaches in the management of Alzheimer's disease

Kandimalla R, Saeed M, Tyagi N, Gupta RC, Aqil F.

Neurosci Biobehav Rev. 2023 Jan;144:104974. doi: 10.1016/j.neubiorev.2022.104974. Epub 2022 Nov 23.

Efficacy and safety of blood derivatives therapy in Alzheimer's disease: a systematic review and meta-analysis

Fei Z, Pan B, Pei R, Chen Z, Du X, Cao H, Li C.

Syst Rev. 2022 Nov 29;11(1):256. doi: 10.1186/s13643-022-02115-y.

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease

Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, Black SE, Blennow K, Fontoura P, Klein G, Assunção SS, Smith J, Doody RS.

Alzheimers Res Ther. 2022 Nov 29;14(1):178. doi: 10.1186/s13195-022-01110-8.

Benefit and safety of antibiotics for Alzheimer's disease: Protocol for a systematic review and meta-analysis

Gao L, Shuai Y, Wen L, Zhang H, Zhang Y, Zhang X.

Medicine (Baltimore). 2022 Nov 25;101(47):e31637. doi: 10.1097/MD.0000000000031637.

The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators

Chen LL, Fan YG, Zhao LX, Zhang Q, Wang ZY.

Bioorg Chem. 2023 Feb;131:106301. doi: 10.1016/j.bioorg.2022.106301. Epub 2022 Nov 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias